Coadministration of metformin or spironolactone enhances efficacy of rosiglitazone in management of PCOS
Sign Up to like & getrecommendations! Published in 2019 at "Gynecological Endocrinology"
DOI: 10.1080/09513590.2019.1675044
Abstract: Abstract The aim of this study was to compare the efficacy and safety of adding metformin or spironolactone to rosiglitazone in women with polycystic ovary syndrome (PCOS). This is a prospective non-randomized study in a… read more here.
Keywords: three groups; coadministration metformin; spironolactone enhances; metformin spironolactone ... See more keywords